Analgesics in Qatar in 2026 records minimal current value growth, as established self-medication habits and increasingly hectic lifestyles sustain demand for everyday pain relief despite economic pressures. Price sensitivity is becoming more important, supporting generics, smaller pack sizes and accessible brands such as Panadrex Pure, while Qatar’s large migrant workforce strengthens demand for reliable, lower-priced paracetamol options. Competition remains highly concentrated, with GSK Consumer Healthcare maintaining a substantial lead through Panadol’s strong recognition, trusted reputation and broad product range. Pharmacies remains the leading distribution channel, supported by extensive choice and professional advice, while digital purchasing is gaining relevance as established pharmacy operators extend access through online platforms, home delivery and more integrated purchasing options. Looking ahead, analgesics is forecast to record moderate value growth as self-medication, wide OTC accessibility and population growth sustain demand. Systemic analgesics is expected to remain the largest area, while topical analgesics/anaesthetic is anticipated to record stronger growth as consumers seek targeted, non-systemic pain relief. Growing interest in natural remedies and holistic therapies is also expected to increase competition for conventional pain-relief products.
Delivery:
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Overview:
Understand the latest market trends and future growth opportunities for the Analgesics industry in Qatar with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Analgesics industry in Qatar, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
The Analgesics in Qatar report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volume and value sizes, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent research methodology, conducted in-country
This report answers:
- What is the market size of Analgesics in Qatar?
- Which are the leading brands in Analgesics in Qatar?
- How are products distributed in Analgesics in Qatar?
- How has the regulatory and operating environment for Analgesics changed in Qatar?
- How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Analgesics
- How significant are wider health concerns and consumer awareness in determining sales?
- Where is future growth expected to be most dynamic?
Key Data Insights
Affordability supports everyday demand despite economic pressures
Digital expansion increases pressure on pharmacy-led purchasing
Migrant workforce demand strengthens lower-priced analgesic brands
Chart 1 Value Sales 2021-2031
Chart 2 Value Sales by Category 2026
Self-medication and OTC accessibility expected to sustain growth
Established brands poised to retain consumer loyalty as demand matures
Holistic approaches set to increase competition for conventional pain relief
Chart 1 Forecast Value Sales 2021-2031
Chart 2 Forecast Value Sales by Category 2026-2031
Panadol’s broad portfolio reinforces GSK Consumer Healthcare’s substantial lead
Brand equity and trusted portfolios remain critical to gaining share
Chart 1 Company Shares 2026
Chart 2 Brand Shares 2026
Pharmacies retain loyalty through product choice and professional advice
Digital access gains relevance as pharmacies extend purchasing beyond stores
Chart 1 Retail Channels 2021-2026
Chart 1 Real GDP Growth 2021-2031
Chart 2 Inflation 2021-2031
Chart 1 Population 2021-2031
Chart 2 Population by Generation 2026
Chart 3 Consumer Expenditure 2021-2031
Country Reports Disclaimer
The following categories and subcategories are included:
Analgesics
-
-
- Adult Acetaminophen
- Adult Aspirin
- Adult Combination Products - Analgesics
- Adult Diclofenac
- Adult Dipyrone
- Adult Ibuprofen
- Adult Ketoprofen
- Adult Naproxen
- Adult OTC Triptans
-
- Paediatric Acetaminophen
- Paediatric Aspirin
- Paediatric Combination Products - Analgesics
- Paediatric Dipyrone
- Paediatric Ibuprofen
- Paediatric Naproxen
-
- Acetaminophen
- Aspirin
- Combination Products - Analgesics
- Diclofenac
- Dipyrone
- Ibuprofen
- Ketoprofen
- Naproxen
- OTC Triptans
-
- Topical Analgesics/Anaesthetic
Analgesics
Analgesics cover systemic and topical pain relievers. Products which include a pain-relief ingredient in addition to another core function are excluded (e.g. a sore throat remedy which includes paracetamol is excluded from the analgesics and instead is included in pharyngeal remedies).
See all of our definitionsWhy buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This report originates from Passport, our Analgesics research and analysis database.
NEW REPORT GUARANTEE
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!